Divi’s Labs dips on patent blow: Analyst sees buy on dips
Divi's Labs slipped to ₹6,545 after MSN won a US patent case over Entresto, its key API. Analyst Prabhat Mittal suggests buying at ₹6,660 with targets of ₹7,070-₹7,270. IIFL sees a 12-13% EBITDA hit and kept a 'reduce' rating. Despite short-term risk, retail sentiment remains bullish as the stock trades near GLP-1 and CDMO-driven valuations.